AL STOCK TRADES
@ALSTOCKTRADES
Followers
7K
Following
3K
Statuses
4K
Wall Street Data Unlocked: We Teach, You Profit. Join Today! 👇🏻
Headquarters: Tucson, Arizona
Joined February 2022
Hey $CLOV Family, We normally keep this level of financial analysis locked behind our proprietary tools, reserved for our most dedicated members. But today, we’re making an unprecedented gesture of good faith by sharing something you won’t find anywhere else — the type of analysis you’d expect at the most elite levels of Wall Street. This is NOT your typical retail investor’s charting. What we’re sharing here is the culmination of advanced financial modeling, including Monte Carlo simulations, mean reversion calculations, and intrinsic value assessments that have undergone millions of iterations. This is big-league stuff, the kind of analysis that hedge funds and multi-billion-dollar institutional players use to spot deeply undervalued opportunities. We’ve applied this high-level, multi-variable statistical analysis to Clover Health CLOV, and the results are nothing short of eye-opening. The conclusion? Clover is fundamentally undervalued — and we’re showing you why.
14
49
292
$HUM to $CLOV -Humana expects a ~10% decline in its Medicare Advantage membership in 2025 due to exiting unprofitable markets, compounded by lower Medicare Star Ratings and rising medical costs. Despite this, the company reaffirmed its 2025 earnings outlook at $16.25 per share, though slightly below analyst expectations, while projecting $126B-$128B in revenue, surpassing forecasts. In Q4 2024, Humana reported strong revenue growth (~10% YoY) but saw a significant earnings decline, with a net loss of $2.16 per share and a ~42% drop in full-year earnings.
1
2
20
because if you look deep within their financials, they’re not servicing Medicare advantage customer quite yet they only have a few so they’re not currently a direct competitor. I think they only have a few lives under management for people that are over the ages of 65. This is where Clover health is actually quite opposite. That is their main businessso there’s a lot of due diligence you’ll need to go through but overall I hope this helps you’re asking the right questions.
1
0
0
@DRockStocks also, I tend to look at fundamentals if an ice cream business is making a lot of money then it doesn’t matter what’s going on regarding what sensational on the news it’s making money. It ultimately is going to translate into shareholder value. I should make a video on this.
1
0
2
@Almaaded Excellent $CLOV people now are slowly starting to catch on to all the individuals that purchased at $.60 congratulations!
0
0
13
Yeah, actually it’s important to have a diversified board. Also, the fact of the matter is @elonmusk just got access to @CMSGov and is using the @DOGE to help solve the spend crisis. $CLOV has a lot of benefit from that but overall that’s why the healthcare sector has been down because of these cost saving measures.
3
1
2